Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $137.0K | $131.0K | ($499.0K) | $6,953.0K | $11.7M | $10.4M | $6,921.0K | $4,417.0K | ($21.4M) | ($18.1M) | ($22.0M) | ($1,982.0K) | ($2,438.0K) | ($2,901.0K) | $7,412.0K | $112.3M | $124.5M | $144.3M | $190.2M | $239.6M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Insmed Incorporated's last 12-month Gross Profit is $262.4M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Insmed Incorporated's Gross Profit growth was 18.9%. The average annual Gross Profit growth rates for Insmed Incorporated have been 27.5% over the past three years, 26.0% over the past five years.